Aetna creates new gene therapy network

October 27, 2021 by Chain Drug Review Aetna, Cellular and Other Innovative Therapies designated network, CVS Health, Gene-based Leading Headlines, Pharmacy

WOONSOCKET, R.I. — Aetna announced on Wednesday the launch of its designated Gene-based, Cellular, and Other Innovative Therapies (GCIT) network. This network is designed to enable members’ access to new therapies that treat and potentially cure rare genetic diseases, while helping to manage the high cost of these therapies. Aetna’s national GCIT network includes access